The distribution of FV-Leiden, prothrombin and plasminogen activator inhibitor gene mutations in patients with obstructive sleep apnea

Basit Öğe Kaydı
dc.contributor.authorGulec Balbay, Ege
dc.contributor.authorKüçük, E.
dc.contributor.authorBalbay, O.
dc.contributor.authorNihat Annakkaya, A.
dc.contributor.authorSılan, Fatma
dc.contributor.authorMeliha Hiz, M.
dc.date.accessioned2025-01-27T19:05:53Z
dc.date.available2025-01-27T19:05:53Z
dc.date.issued2014
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.issn1015-8146
dc.identifier.issue1
dc.identifier.scopus2-s2.0-84899109971
dc.identifier.scopusqualityN/A
dc.identifier.startpage69
dc.identifier.urihttps://hdl.handle.net/20.500.12428/14027
dc.identifier.volume25
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherEditions Medecine et Hygiene
dc.relation.ispartofGenetic Counseling
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20250125
dc.subjectblood clotting factor 5 Leiden; plasminogen activator inhibitor; prothrombin; adult; controlled study; DNA polymorphism; female; gene frequency; gene mutation; genetic association; genotype; heterozygote; homozygote; human; letter; major clinical study; male; polymerase chain reaction; polysomnography; questionnaire; risk factor; sleep disorder; sleep disordered breathing
dc.titleThe distribution of FV-Leiden, prothrombin and plasminogen activator inhibitor gene mutations in patients with obstructive sleep apnea
dc.typeLetter

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu